Navigation Links
Scientist-novelist back with second book at cell biology meeting
Date:12/7/2011

Denver, CO- It's about living in two worlds times two, says Steve Caplan, the Israeli-born but American-now, scientist-novelist at the University of Nebraska Medical Center in Omaha. Caplan who has just published his second novel. "Welcome Home, Sir," about the divisions that science and national identity create in his scientist-novelist, Israeli-American hero.

Published by the Anaphora Literary Press of Cochran Georgia, "Welcome Home, Sir" is the story of Dr. Ethan Meyer, a dynamic, highly successful biochemical researcher at a large American university whose life is coming apart at the seams. The cracks come from tensions between science and ordinary life, between being an Israeli and raising American children, and most dramatically between Dr. Meyer's daily life and his haunting memories from combat service in the Israel Defense Forces.

"I think there may be more Israeli scientists today in the US than in Israel," says writer Caplan, "and it sets up a peculiar dynamic between these scientists and their families here in America."

Caplan was in Denver to present new data on cellular endocytic trafficking at the American Society for Cell Biology's 51st Annual Meeting and to talk about his second novel. He published his first novel, "Matter Over Mind," in 2010. It is extremely realistic portrait of a fictional biomedical researcher struggling with grant troubles, eccentric lab members, and troublesome colleagues, while personal problems pile up.
'/>"/>

Contact: John Fleischman
jfleischman@ascb.org
513-706-0212
American Society for Cell Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Is a stranger trustworthy? Youll know in 20 seconds
2. World Record in Fingerprint Identification: DERMALOG Correctly Identifies 129 Million Fingerprints in one Second
3. Rutgers neuroscientist says protein could prevent secondary damage after stroke
4. Carnegie partners with USA Science & Engineering Festival for second year
5. AACR to host second Frontiers in Basic Cancer Research Conference
6. Aware, Inc. Reports Second Quarter 2011 Financial Results
7. Aware, Inc. Reports Second Quarter 2011 Financial Results
8. 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
9. PSA test for men could get a second life for breast cancer in women
10. NJIT receives second part of $1M gift to chemical engineering department
11. Malaria against malaria: A pre-existing malaria infection can prevent a second infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... of a United States multicenter, prospective clinical study that demonstrates the accuracy ... test capable of identifying clinically significant acute bacterial and viral respiratory tract ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
Breaking Biology Technology: